Investor Stock List
Ranked #3,740 of 8,699 institutional investors

Sector Gamma AS

Oslo, Q8

$479M
US stock portfolio at live prices · today −$7.6M (−1.56%)
Market closed. Prices as of Nov 20, 7:41 AM ET
Value at quarter end (Q3 2026)
$485M
Change from Q2 2026
+$24.0M (+5.20%)
Positions
37 · 6 new, 5 sold out
Filed
Nov 12, 2026

Not counted in the ranking: none$54.5M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
BMY 7.46%PFE 7.29%MRK 5.35%GEHC 4.39%BMRN 3.76%
StockSharesValue, live% of portfoliovs Q2 2026
BMY Bristol-Myers Squibb Company612,962$35.8M7.46%Reduced −16%
PFE Pfizer Inc.1,267,334$34.9M7.29%Added +26%
MRK Merck & Co., Inc.193,044$25.6M5.35%Reduced −11%
GEHC GE HealthCare Technologies Inc.256,906$21.0M4.39%Added +24%
BMRN BioMarin Pharmaceutical Inc.293,293$18.0M3.76%Reduced −1%
INCY Incyte Corporation155,100$18.0M3.75%Reduced −9%
BIIB Biogen Inc.66,646$16.5M3.44%Added +23%
BDX Becton, Dickinson and Company75,630$16.1M3.36%Reduced −19%
CVS CVS Health Corporation196,574$15.7M3.28%Added +27%
ELV Elevance Health, Inc.40,229$15.7M3.28%Reduced −10%
ABT Abbott Laboratories141,741$14.7M3.07%Reduced −4%
DHR Danaher Corporation63,381$14.4M3.01%New
BRKR Bruker Corporation217,352$13.5M2.82%Added +43%
ZBH Zimmer Biomet Holdings, Inc.131,484$13.3M2.79%Reduced −8%
BSX Boston Scientific Corporation308,128$13.2M2.77%Added +154%
REGN Regeneron Pharmaceuticals, Inc.14,184$13.1M2.73%Reduced −10%
BIO Bio-Rad Laboratories, Inc.33,350$12.3M2.56%Unchanged
LH Labcorp Holdings Inc.31,019$11.4M2.39%Added +19%
CAH Cardinal Health, Inc.40,301$11.0M2.29%Reduced −1%
IQV IQVIA Holdings Inc.42,283$10.6M2.21%Reduced −46%
CNC Centene Corporation142,405$9.3M1.95%Reduced −12%
AVTR Avantor, Inc.606,088$9.2M1.91%Reduced −33%
IONS Ionis Pharmaceuticals, Inc.330,037$9.0M1.88%Added +74%
UNH UnitedHealth Group Incorporated20,000$6.6M1.38%New
PTCT PTC Therapeutics, Inc.112,000$6.5M1.36%Added +12%
EW Edwards Lifesciences Corporation60,402$6.3M1.31%Unchanged
HCA HCA Healthcare, Inc.10,000$4.6M0.96%New
TNDM Tandem Diabetes Care, Inc.267,091$4.5M0.94%Unchanged
TVTX Travere Therapeutics, Inc.68,000$3.3M0.69%Reduced −15%
KURA Kura Oncology, Inc.433,012$3.2M0.66%Unchanged
IOVA Iovance Biotherapeutics, Inc.388,466$2.8M0.59%Reduced −60%
VRDN Viridian Therapeutics, Inc.84,867$2.7M0.56%New
MDGL Madrigal Pharmaceuticals, Inc.6,500$2.6M0.54%New
DNLI Denali Therapeutics Inc.137,718$2.5M0.52%New
CYTK Cytokinetics, Incorporated45,000$2.3M0.48%Unchanged
SNDX Syndax Pharmaceuticals, Inc.241,739$2.2M0.46%Unchanged
ARDX Ardelyx, Inc.686,844$2.1M0.44%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TMO Thermo Fisher Scientific Inc.33,584$23.1M
AMGN Amgen Inc.26,281$11.5M
DXCM DexCom, Inc.102,122$8.2M
OGN Organon & Co.270,781$3.8M
NTLA Intellia Therapeutics, Inc.185,177$1.8M